These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 301897)

  • 21. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 22. Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors.
    Holden HT; Haskill JS; Kirchner H; Herberman RB
    J Immunol; 1976 Aug; 117(2):440-6. PubMed ID: 1084897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
    Wood GW
    Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and cytotoxic reactivity of inflammatory cells recovered from progressing or regressing syngeneic UV-induced murine tumors.
    Lill PH; Fortner GW
    J Immunol; 1978 Nov; 121(5):1854-60. PubMed ID: 309483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro with syngeneic tumor cells.
    Brunner KT; MacDonald HR; Cerottini JC
    J Immunol; 1980 Apr; 124(4):1627-34. PubMed ID: 6154076
    [No Abstract]   [Full Text] [Related]  

  • 26. [Functional activity of the lymphocytes of mouse lymph nodes in a system of viral carcinogenesis].
    Umanskiĭ IuA; Evsev'eva AI; Semenova-Kobzar' RA; Kushko LIa
    Tsitologiia; 1979 Feb; 21(2):191-5. PubMed ID: 432958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M; Pearson G; Redmon L; Winters E; Kasuga S
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting passive monoclonal antibody therapy of Moloney sarcoma in BALB/c mice.
    Kennel SJ; Lankford PK; Flynn KM; Winegar R
    Cancer Res; 1985 Aug; 45(8):3782-9. PubMed ID: 2410101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of experimental tumors in mice by treatment with concanavalin A.
    Ekstedt RD
    J Natl Cancer Inst; 1979 Oct; 63(4):1065-9. PubMed ID: 480379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunity to tumours of the murine leukaemia-sarcoma virus complex.
    Owen JJ; Seeger RC
    Br J Cancer Suppl; 1973 Aug; 1():26-34. PubMed ID: 4374230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppression by spleen cells from Moloney leukemia. III. Evidence for a suppressor cell that is not the leukemic, virus-producing cell.
    Cerny J; Grinwich KD; Stiller RA
    J Immunol; 1977 Sep; 119(3):1097-101. PubMed ID: 330747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of adhesion molecules in the immune reaction to M-MSV-induced tumors.
    Rosato A; Bronte V; Mandruzzato S; Zambon A; Calderazzo F; Biasi G; Zanovello P; Collavo D
    Int J Cancer Suppl; 1992; 7():24-7. PubMed ID: 1385341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-T-cell-mediated cytotoxicity in mice with tumors induced by Moloney murine sarcoma virus (M-MuSV). II. Granulocyte-mediatd cytotoxicity against autochthonous target cells isolated from M-MuSV-induced tumors.
    Becker S; Haskill S
    J Natl Cancer Inst; 1980 Aug; 65(2):469-75. PubMed ID: 6249952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids.
    Dillehay DL; Shealy YF; Lamon EW
    Cancer Res; 1989 Jan; 49(1):44-50. PubMed ID: 2783245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytolytic activity of murine CD4+ T cell clones correlates with IFN-gamma production in mouse strains having a BALB/c background.
    McKisic MD; Lancki DW; Fitch FW
    J Immunol; 1993 May; 150(9):3793-805. PubMed ID: 8097225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).
    Lamon EW; Skurzak HM; Andersson B; Whitten HD; Klein E
    J Immunol; 1975 Apr; 114(4):1171-6. PubMed ID: 1117138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas.
    Russell SW; McIntosh AT
    Nature; 1977 Jul; 268(5615):69-71. PubMed ID: 887150
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
    Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moloney murine sarcoma virus 349 induces Kaposi's sarcomalike lesions in Balb/c mice.
    Stoica G; Hoffman J; Yuen PH
    Am J Pathol; 1990 Apr; 136(4):933-47. PubMed ID: 2158239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.